Hermetically sealed RFID microelectronic chip connected to a biocompatible RFID antenna
An implantable radio frequency identification (RFID) tag includes a hermetically sealed biocompatible housing for an active implantable medical device (AIMD), an RFID microelectronics chip is disposed within the housing, and a biocompatible antenna extends from the RFID microelectronic chip and exteriorly of the housing. In a preferred form of the invention, the antenna is disposed within a header block of the AIMD, and the RFID chip is disposed within the AIMD housing.
Latest Greatbatch Ltd. Patents:
- Method for manufacturing a co-axial glass-to-metal seal for a case-neutral electrochemical cell
- Self-centering polymeric washer that prevents misalignment when positioned between a feedthrough and a circuit board supporting EMI filter capacitors for a medical device
- High-voltage electrical insulation for use in active implantable medical devices circuit board connectors
- Exterior insulator for an implantable power source
- Header connection system for implantable medical device
The present application is a reissue application of U.S. patent application Ser. No. 12/728,538, filed on Mar. 22, 2010, now U.S. Pat. No. 8,248,232, which is a continuation-in-part of application Ser. No. 12/566,223, filed on Sep. 24, 2009, now U.S. Pat. No. 8,253,555, which is a continuation-in-part of application Ser. No. 11/307,145, filed on Jan. 25, 2006, now U.S. Pat. No. 7,916,013.
BACKGROUND OF THE INVENTIONThis invention relates generally to methods of identifying implanted medical devices. More specifically, this invention relates to implantable and biocompatible radio frequency identification (RFID) tags and associated antennas which may be used with medical devices or for general personal identification purposes.
There are known in the art various methods for identifying implanted medical devices. One such method is the use of X-ray identification tags encapsulated within header blocks of pacemakers or implantable cardioverter defibrillators (ICD). Such X-ray identification tags can be read on an X-ray of the implanted device and provide information to the physician. The information so provided is limited due to space and typically includes only the manufacturer and model number of the implanted device.
It would be beneficial if physicians were able to obtain additional information about an implanted device and/or a patient from an implanted identification tag. Such beneficial information includes, in addition to the manufacturer and model number of the device, the serial number of the device, the treating physician's name and contact information and, if authorized by the patient, the patient's name, contact information, medical condition and treatment, and other relevant information.
Currently, most active implantable medical device (AIMD) patients carry some sort of identification. This could be in the form of a card carried in the wallet or an ID bracelet indicating, for example, that they are a pacemaker wearer of a certain model and serial number. However, such forms of identification are often not reliable. It is quite common for an elderly patient to be presented at the emergency room (ER) of a hospital without their wallet and without wearing any type of a bracelet. In addition, there have been a number of situations where the patient (due to dementia or Alzheimer's, etc.) cannot clearly state that he or she even has a pacemaker.
Oftentimes the ER physician will palpitate the patient's chest and feel that there is an implanted device present. If the patient is comatose, has low blood pressure, or is in another form of cardiac distress, this presents a serious dilemma for the ER. At this moment in time, all that the ER knows is that the patient has some sort of an AIMD implant in his or her chest. It could be a pacemaker, a cardioverter defibrillator, or even a vagus nerve stimulator or deep brain stimulator.
What happens next is both laborious and time consuming. The ER physician will have various manufacturers' internal programmers transported from the hospital cardiology laboratory down to the ER. ER personnel will then try to interrogate the implantable medical device to see if they can determine what it is. For example, they might first try to use a Medtronic programmer to see if it is a Medtronic pacemaker. Then they might try a St. Jude, a Guidant, an ELA, a Biotronik or one of a number of other programmers that are present. If none of those programmers work, then the ER physician has to consider that it may be a neurostimulator and perhaps go get a Cyberonics or Neuropace programmer.
It would be a great advantage and potentially lifesaving if the ER physician could very quickly identify the type of implant and model number. In certain cases, for example, with a pacemaker patient who is in cardiac distress, with an external programmer they could boost the pacemaker output voltage to properly recapture the heart, obtain a regular sinus rhythm and stabilize blood pressure. All of the lost time running around to find the right programmer, however, generally precludes this. Accordingly, there is a need for a way to rapidly identify the type and model number of an active implantable medical device so that the proper external programmer for it can be rapidly identified and obtained.
It is also important to note that lead wire systems generally remain in the human body much longer than the active implantable medical device itself. For example, in the case of a cardiac pacemaker, the cardiac pacemaker batteries tend to last for 5 to 7 years. It is a very difficult surgical procedure to actually remove leads from the heart once they are implanted. This is because the distal TIP and other areas of the leads tend to become embedded and overgrown (encapsulated) by tissues. It often takes very complex surgical procedures, including lasers or even open heart surgery, to remove such lead wire systems. When a pacemaker is replaced, the pectoral pocket is simply reopened and a new pacemaker is plugged into the existing leads. However, it is also quite common for leads to fail for various reasons. They could fail due to breakdown of electrical insulation or they could migrate to an improper position within the heart. In this case, the physician normally snips the leads off and abandons them and then installs new leads in parallel with the old abandoned leads.
Abandoned leads can be quite a problem during certain medical diagnostic procedures, such as MRI. It has been demonstrated in the literature that such leads can greatly overheat due to the powerful magnetic fields induced during MRI. Accordingly, it is important that there be a way of identifying abandoned leads and the lead type. Also, there is a need to identify such abandoned leads to an Emergency Room physician or other medical practitioner who may contemplate performing a medical diagnostic procedure on the patient such as MRI. This is in addition to the need to also identify the make and model number of the active implantable medical device.
It is also important to note that certain lead systems are evolving to be compatible with a specific type of medical diagnostic procedure. For example, MRI systems vary in static field strength from 0.5 Tesla all the way above 10 Tesla. A very popular MRI system, for example, operates at 3 Tesla and has a pulse RF frequency of 128 MHz. There are specific certain lead systems that are evolving in the marketplace that would be compatible with only this type of MRI system. In other words, it would be dangerous for a patient with a lead wire designed for 3 Tesla to be exposed to a 1.5 Tesla system. Thus, there is also a need to identify such lead systems to Emergency Room and other medical personnel when necessary. For example, a patient that has a lead system that has been specifically designed for use with a 3 Tesla MRI system may have several pacemaker replacements over the years.
It is already well known in the prior art that RFID tag implants can be used for animals, for example, for pet tracking. They are also used in the livestock industry. For example, RFID tags can be placed in or on cattle to identify them and track certain information. An injectable RFID tag for humans has also been developed. However, none of the current RFID tags have been designed to have long term reliability, hermeticity, and biocompatibility within the body fluid environment.
In the prior art, RFID tags have been encapsulated in plastic or placed in a plastic or glass tube with an epoxy infill. However, as will be discussed more fully below, none of these materials provide a truly hermetic seal against body fluids.
With reference now to
One approach would be to hermetically seal the RFID chip and its complete loop antenna. However, when one fully contemplates hermetically sealing an RFID chip with a very large multi-turn loop antenna, one realizes that such an approach becomes entirely impractical. The hermetic seal package would simply be too large to be effectively associated with a medical implant.
Accordingly, there is a need for an improved medical identification tag that can store additional information about an implanted device and/or a patient, without unduly increasing the size of the identification tag or jeopardizing the operation of the implanted device or the health of the patient. The present invention meets these needs by providing an RFID tag whose electronic chip is enclosed within an AIMD hermetic housing, and a biocompatible antenna that is disposed outside of the AIMD housing. The RFID tag of the present invention is capable of storing information about the medical device, the physician, and the patient, as described above.
SUMMARY OF THE INVENTIONIn general, the present invention is directed to a system for identifying implants within a patient, comprising an implantable medical device, a radio frequency identification (RFID) tag having a hermetically sealed chip and biocompatible antenna and being associated with the implantable medical device, the RFID tag containing information relating to the patient and/or the implantable medical device, and an interrogator capable of communicating with the RFID tag.
Such implantable medical devices may include active implantable medical devices (AIMD) such as a cardiac pacemaker, an implantable defibrillator, a congestive heart failure device, a hearing implant, a cochlear implant, a neurostimulator, a drug pump, a ventricular assist device, an insulin pump, a spinal cord stimulator, an implantable sensing system, a deep brain stimulator, an artificial heart, an incontinence device, a vagus nerve stimulator, a bone growth stimulator, a gastric pacemaker, a Bion, or a prosthetic device and component parts thereof, including lead wires or abandoned lead wires.
More particularly, the present invention relates to an implantable radio frequency identification (RFID) tag, comprising: (1) a hermetically sealed biocompatible housing for an active implantable medical device (AIMD); (2) an RFID microelectronics chip disposed within the housing; and (3) a biocompatible antenna extending from the RFID microelectronics chip and exteriorly of the housing. The antenna may be disposed within a non-hermetically sealed portion of the AIMD, such as the AIMD header block.
With the biocompatible antenna disposed within the AIMD header block, at least one lead extends through a hermetic terminal associated with the AIMD housing to connect the antenna to the RFID tip which is disposed within the AIMD housing. The RFID chip may be disposed either adjacent to the hermetic terminal or remotely within the housing relative to the hermetic terminal. Moreover, at least one lead may comprise a unitary extension of the antenna and/or an active lead which extends through the hermetic terminal in non-conductive relation with the AIMD housing, and a ground lead extending through the AIMD housing in conductive relation.
The AIMD housing preferably has a leak rate of no more than 10−7 cubic centimeters per second. Preferably, the housing is taken from the group including biocompatible metals and alloys such as titanium and/or stainless steel, ceramic, glass, porcelain, sapphire and composites thereof, and specialty polymer composites, where the housing is of a non-conductive material, such as ceramic, glass or the like, then a metal coating would typically be used to provide an overall electromagnetic shield. A desiccant may further be disposed within the housing.
The RFID chip may be read-only or readable/writable, and may comprise a portion of a system which includes an interrogator for electromagnetically communicating with the RFID chip. The interrogator may be a read-only or a reader/writer device and, in turn, may be placed in communication with a computer or a computer network.
The RFID chip may include information pertaining to the AIMD and/or to a patient in which the RFID tag is implanted.
The antenna may be wound around a ferrite-based core comprising a high temperature sintered ferrite-based material having a biocompatible dielectric material at least partially coating the ferrite-based material. Such biocompatible dielectric material may comprise parylene, ETFE, PTFE, polyimide, polyurethane, or silicone. Preferably, the ferrite-based core is comprised of a ferrite material that will not exhibit permanent remanence after exposure to MRI fields.
A sensor may be conductively coupled to the RFID microelectronics chip. The sensor may be disposed either exteriorly of the AIMD housing or within the AIMD housing. The sensor may measure and the RFID tag may transmit measured properties in real time.
The RFID tag's biocompatible antenna may comprise at least one biocompatible conductive material taken from the group of: titanium, platinum and platinum/iridium alloys, tantalum, niobium, zirconium, hafnium, nitinol, Co—Cr—Ni alloys such as MP35N, Havar®, Elgiloy®, stainless steel, gold and its various alloys, palladium, pyrolytic carbon, or any other noble metal.
The RFID tag's biocompatible antenna may also comprise a conductive metal compound taken from any of the following: ZrC, ZrN, TiN, NbO, TiC and TaC, or a substrate and a conductive polymer taken from the group of: Polyethylene, oxide with ionic addition such as NaCl, Polyurethane, Silicone, Polyesters, Polycarbonate, polyethylene, Polyvinyl Chloride, Polypropylene, Methylacrylate, or Para-xylylene.
Other features and advantages of the present invention will become apparent from the following more detailed description, taken in conjunction with the accompanying drawings which illustrate, by way of example, the principles of the invention.
The accompanying drawings illustrate the invention. In such drawings:
The present invention is directed to a radio frequency identification (RFID) system for use with active implantable medical devices (AIMDs) and an associated RFID tag. Specifically, the RFID system comprises an RFID tag implanted in a patient's body and associated with an implanted AIMD, and an interrogator in communication with the RFID tag. The novel tag comprises an electronic RFID chip disposed inside the hermetically sealed housing of an AIMD, and an external biocompatible antenna.
An RFID interrogator 20, also known as a hand held scanner or reader, transmits an electromagnetic field pulse 22 which is intercepted by the antenna 18 that is part of the implanted RFID tag 12. The implanted RFID tag 12 is generally passive, which means that it does not have its own self-contained source of energy such as a battery (although it can). The electromagnetic field pulse 22 that comes from the interrogator 20 resonates with the antenna 18 and the RFID chip 16 providing energy for the RFID chip 16 to generate a signal and the antenna 18 to emit a return pulse 24. There is usually an energy storage and resonant capacitor 158 (
Ideally, the medical device manufacturer would have a special RFID reader associated with their manufacturing line. For example, a cardiac pacemaker manufacturer, at the point of final sterilization and packaging, would use a production line barcode reader-RFID writer to read a barcode associated with the production lot traveler or packaging, and then the production line RFID writer would write this information to the RFID tag that is embedded in or associated with the pacemaker or other medical device. This would go into an area of permanent memory on the RFID tag. There would also be an area of volatile memory that the doctor could optionally use later to enter information about the patient, the patient's medical condition or even information about the implanting physician all at the time of implant. This would typically be done with informed patient consent. Of course, these principles are applicable to any external or internal medical device.
RFID standards are evolving worldwide at various frequencies generally between 125 kHz and 915 MHz. For example, a 915 MHz protocol is generally evolving to be used for retail goods and inventory control. However, due to the high frequency, the 915 MHz protocols are not very useful for human implants. The reason for this is that humans are largely water and 915 MHz fields are greatly affected by the presence of water. The preferred embodiment is another RFID protocol which operates at 13.56 MHz which is ideal for an implantable RFID tag. The 13.56 MHz lower frequency will readily penetrate and communicate with the tag instead of reflecting off of the skin surface or being absorbed. There are other lower frequency RFID systems, for example, in the 50 to 135 kHz range which would also be ideal.
A non-hermetically sealed RFID tag 12 is encapsulated within the molded header block 38 of the AIMD 10. Such molded header connector blocks are common in the industry and are designated by ISO Standards IS-I, DF-1 or IS-4 or the equivalent. The header block 38 of
Prior art RFID tags (like the Verichip) that are used for both animal and sometimes for human implant have a serious deficiency in that they are not truly hermetically sealed. These devices often use a cylindrical glass cup which is filled with epoxy or other types of polymer materials such as silicone or the like. A deficiency with such seals is that over long periods of time moisture will slowly penetrate and reach the sensitive electronic circuits. When moisture reaches electronic circuits under low bias voltage conditions, dendrites and tin whiskers can form thereby shorting out or reducing insulation resistancy to electronic components. Accordingly, the RFID chip should be completely hermetically sealed in a container with a minimum helium leak rate of 1×10−7 cubic centimeters per second. As used herein “hermetically sealed” means a leak rate of 10−7 cubic centimeters per second or slower. This is in sharp contrast to prior art polymer fill systems which achieve at most a helium leak rate of around 1×10−5 cubic centimeters per second. In the most preferred embodiment described herein, the electronic chip portion of the RFID tag 12 is hermetically sealed inside the overall housing of the AIMD.
Since the RFID chip 16 is generally constructed of materials that are not long-term biocompatible and body fluid resistant, it is important to prevent body fluids from reaching the RFID chip 16. Even if the RFID chip 16 is embedded deeply within a molded polymer header block 38 as illustrated in
In order for the RFID interrogator 20 to be able to read a tag 12 embedded within the human body, it must generate a very powerful yet relatively low frequency field. Such interrogators 20 are most effective when held within ten centimeters of the implant.
In
A hermetically sealed package 44 contains the RFID chip therein. There are biocompatible electrical connection terminal pins 46 and 48 between the antenna 42 and the hermetically sealed package 44. These would typically be laser welds or brazes of all biocompatible materials or biocompatible solders or conductive polymers. In other words, no non-biocompatible solder joint or other such non-biocompatible connection would be exposed to body fluids. An alternative would be to use a biocompatible thermally conductive adhesive. Biocompatible metals and alloys that can be used for the electronic network components or component network or the connection materials include all of the metals and alloys of titanium, platinum and platinum iridium alloys, tantalum, niobium, zirconium, Hafnium, nitinol, Co—Cr—Ni alloys such as MP35N, Havar®, Elgiloy®, stainless steel and gold. There are also a number of conductive metal compounds that can be used including ZrC, ZrN, TiN, NbO, TiC, TaC, and Indium Oxide/Indium Tin Oxide (Transparent Conductive Oxides). Commercially available biocompatible electrically conductive epoxies are manufactured by Epoxy Technology, Inc, in Billerica, Mass. For example Epoxy technology EPOTEK H81 features a biocompatible epoxy which is gold filled (www.epotek.com). The conductive connection materials are typically thermal-setting, brazing, welding or special biocompatible soldering materials. So as to be non-migratable, these materials are selected from the group consisting of: gold, gold alloy, platinum, gold-filled-thermal-setting conductive material, platinum-filled-thermal-setting conductive material, gold-bearing glass frit, TiCuSil, CuSil, and gold-based braze.
Referring once again to
Referring once again to
The entire non-toxic biocompatible RFID tag 40 of
The novel biocompatible antenna 42 and hermetically sealed RFID chip 50 of the present invention does not need to be associated with a pacemaker or other type of AIMD 10. The RFID chip 50 and associated biocompatible and non-toxic antenna 42 could be implanted in the abdominal area, into the arm or even the buttocks. Since these areas are all subject to some movement, flexibility of the antenna 42 is important. The antenna 42 and hermetically sealed RFID chip 50 could be over-molded with silicone or other thin biocompatible but flexible material. Flexibility of the entire structure is important because no matter where you implant this in the human body, it is subject to some motion. The arm would be an extreme example where motion could occur. The novel RFID tag 40 need not be for identification of a medical implant only. It could also be used generally for human identification. This would include applications where lights in a building could be turned on and off automatically as the implanted RFID tag 40 is sensed, doors could be opened and the like. The RFID chip 50 could also contain encrypted information such as Social Security Number, credit card information and the like. This would facilitate automated checkout from retail stores and the like.
Referring to
The structure illustrated in
From the foregoing it will be appreciated that a novel aspect of the present invention resides in providing a relatively large non-hermetically sealed biocompatible multi-turn RFID loop antenna 42 which is electrically connected to a miniature RFID chip 50 that is enclosed within its own hermetically sealed miniature package 44. The hermetic package 44 can be very small and the loop antenna 42 can be relatively large wherein the entire RFID tag 40 is both highly reliable, resistant to body fluids and completely biocompatible. In a particularly preferred embodiment, the hermetic seal for the RFID chip 50 is the overall shielded metallic housing 32 of the AIMD 10. The external antenna structure 42 is adaptable for being molded into the header block 38, for example, for a cardiac pacemaker 10 or, alternatively it can be implanted in other locations in the human body.
The hermetically sealed RFID chip with fixation device can be used to attach to one or more abandoned leads in the pectoral pocket. This is very useful whether or not the patient receives a new pacemaker or AIMD, implant or not. That is, if a patient that has reverted to normal sinus rhythm and no longer needs a pacemaker and has abandoned leads, the radiology department can quickly tell through the RFID scan whether or not abandoned lead wires are present. As mentioned, this is extremely important to prevent inadvertent MRI on such a patient. In the past, it has been shown that abandoned leads can heat up so much that ablation of cardiac tissue and even perforation of cardiac walls can occur. It is, therefore, a feature of the present invention that both the lead wire system and the AIMD can be separately identified.
It will also be appreciated that the present invention provides an improved implantable radio frequency identification (RFID) tag that may be used advantageously with an active implantable medical device (AIMD) wherein the RFID microelectronics chip is disposed within the AIMD housing and the biocompatible antenna extends from the RFID microelectronics chip exteriorly of the housing, for example, into the non-hermetically sealed header block for the AIMD. At least one of the leads connecting the antenna to the RFID chip will normally extend through the hermetic terminal associated with the AIMD housing. The RFID chip may be disposed adjacent to the hermetic terminal, or be remotely disposed within the housing relative to the hermetic terminal. The present invention advantageously utilizes the hermetically sealed housing for the AIMD as a hermetically sealed biocompatible container to prevent the RFID microelectronics chip from coming into contact with body fluids or tissue.
Although several embodiments have been described in detail for purposes of illustration, various modifications may be made without departing from the scope and spirit of the invention. Accordingly, the invention is not to be limited, except as by the appended claims.
Claims
1. An implantable medical device, comprising:
- a) a hermetically sealed biocompatible housing;
- b) an RFID microelectronics chip disposed within the housing;
- c) an antenna wire having a first end portion electrically connected to a first end of the RFID chip inside the housing and extending along a length to a second end portion electronically connected to a second end of the RFID chip inside the housing with at least an intermediate portion of the length of the antenna wire between the first and second end portions residing outside the housing; and
- d) a sealing material that hermetically seals against an outer surface of the first and second end portions of the antenna wire and against respective perimeter openings in the housing through which the antenna wire extends so that the housing has a helium leak rate of no more than 10−7 cubic centimeters per second, and
- e) wherein the intermediate portion of the antenna wire external to the housing serves as an antenna for the RFID microelectronics chip.
2. The implantable medical device of claim 1 wherein the housing has a helium leak rate of no more than 10−7 cubic centimeters per second.
3. The implantable medical device of claim 2 1 wherein the housing is of a material selected from the group consisting of biocompatible metals and alloys, ceramic, glass, porcelain, sapphire and composites thereof, and specialty polymer composites.
4. The implantable medical device of claim 3 including a desiccant within the housing.
5. The implantable medical device of claim 3 including an encapsulant within the housing surrounding at least a portion of the RFID chip.
6. The implantable medical device of claim 5 wherein the encapsulant is comprised of a thermal-setting polymer or a silicone material.
7. The implantable medical device of claim 1 wherein the housing includes a cap hermetically sealed to an open end of a housing container.
8. The implantable medical device of claim 1 wherein the RFID chip is read-only or readable/writable.
9. The implantable medical device of claim 1 wherein the RFID chip is communicable with an external device at a radio frequency of from 125 kHz to 915 MHz.
10. The implantable medical device of claim 9 wherein the RFID chip is communicable with an external device at a radio frequency of approximately 13.56 MHz.
11. The implantable medical device of claim 1 wherein the RFID chip includes information relating to a patient in which the medical device is implanted.
12. The implantable medical device of claim 1 wherein the container, RFID chip, and at least the first and second end portions of the antenna wire are embedded within a non-conductive biocompatible material.
13. The implantable medical device of claim 12 wherein the biocompatible material comprises a disc of a material selected from the group consisting of silicone, epoxy, and a medical grade plastic.
14. The implantable medical device of claim 1 wherein the intermediate portion, of the antenna wire is wound around a ferrite-based core.
15. The implantable medical device of claim 14 wherein the ferrite-based core comprises a high temperature sintered ferrite-based material.
16. The implantable medical device of claim 15 including a biocompatible dielectric material at least partially coating the ferrite-based material.
17. The implantable medical device of claim 16 wherein the biocompatible dielectric material is selected from the group consisting of parylene, ETFE, PTFE, polyimide, polyurethane, and silicone.
18. The implantable medical device of claim 14 wherein the ferrite-based core is comprised of a ferrite material that will not exhibit permanent remanence after exposure to MRI fields.
19. The implantable medical device of claim 1 including a sensor conductively coupled to the RFID microelectronics chip.
20. The implantable medical device of claim 19 wherein the sensor is disposed exterior of the hermetically sealed housing.
21. The implantable medical device of claim 19 wherein the sensor is disposed within the hermetically sealed housing.
22. The implantable medical device of claim 19 wherein the RFID chip is capable of transmitting data measured by the sensor in real time.
23. The implantable medical device of claim 2 1 wherein the measurable data comprises the activity of a human body.
24. The implantable medical device of claim 1 wherein the intermediate portion of the antenna wire is a multi-turn antenna.
25. The implantable medical device of claim 1 wherein the first and second end portions of the antenna wire are first and second feedthrough wires that are hermetically sealed in the respective openings in the housing and opposed end of the intermediate portion of the antenna wire are electrically connected to the first and second feedthrough wires.
26. The implantable medical device of claim 1 wherein the hermetically sealed housing is the housing for the active implantable medical device.
27. The implantable medical device of claim 1 wherein the hermetically sealed housing s of titanium or stainless steel.
28. An implantable medical device, comprising:
- a) a hermetically sealed biocompatible housing;
- b) an RFID microelectronics chip disposed within the housing;
- c) an antenna wire having a first end portion electrically connected to a first end of the RFID chip inside the housing and extending along a length to a second end portion electronically connected to a second end of the RFID chip inside the housing with at least an intermediate portion of the length of the antenna wire between the first and second end portions residing outside the housing; and
- d) wherein a wall of the housing hermetically seals against an outer surface of the first and second end portions of the antenna wire so that the housing has a helium leak rate of no more than 10−7 cubic centimeters per second, and
- e) wherein the intermediate portion, of the antenna wire external to the housing serves as an antenna for the RFID microelectronics chip.
29. The implantable medical device of claim 28 wherein the housing has a helium leak rate of no more than 10−7 cubic as centimeters per second.
30. An implantable medical device, comprising:
- a) a hermetically sealed biocompatible housing;
- b) an RFID microelectronics chip disposed within the housing;
- c) a first feedthrough, wire comprising a first proximal end electrically connected to the RFID chip and a first distal end residing outside the hermetically sealed housing, wherein a first sealing material hermetically seals against an outer surface of the first feedthrough wire and against a first perimeter opening in the housing through which the first feedthrough wire extends;
- d) a second feedthrough wire comprising a second proximal end electrically connected to the RFID chip and a second distal end residing outside the hermetically sealed housing, wherein a second sealing material hermetically seals against an outer surface of the second feedthrough wire and against a second perimeter opening in the housing through which the second feedthrough wire extends so that the housing has a helium leak rate of no more than 10−7 cubic centimeters per second; and
- e) an antenna wire having a first end electrically connected to the first distal end of the first feedthrough wire outside the housing and extending along a length to a second end electronically connected to the second distal end of the second feedthrough wire outside the housing.
31. The implantable medical device of claim 30 wherein the housing has a helium leak rate of no more than 10−7 cubic centimeters per second.
32. A medical system comprising:
- a) an implantable medical device;
- b) hermetically sealed biocompatible housing that is either contained inside the implantable medical device or contacted, to an outer surface thereof;
- c) an RFID microelectronics chip disposed within the housing;
- d) an antenna wire having a first end portion electrically connected to a first end of the RFID chip inside the housing and extending along a length to a second end portion electronically connected to a second end of the RFID chip inside the housing with at least an intermediate portion of the length of the antenna wire between the first and second end portions residing outside the housing; and
- e) a sealing material that hermetically seals against an outer surface of the first and second end portions of the antenna wire and against respective perimeter openings in the housing through which the antenna wire extends so that the housing has a helium leak rate of no more than 10−7 cubic centimeters per second, and
- g) wherein the intermediate portion of the antenna wire external to the housing serves as an antenna for the RFID microelectronics chip.
33. The system of claim 32 wherein the housing has a helium leak rate of no more than 10−7 cubic centimeters per second.
34. The system of claim 32 including an interrogator for electromagnetically communicating with the RFID chip.
35. The system of claim 33 32 wherein the interrogator is a read only or a reader/writer device.
36. The system of claim 33 32 wherein the interrogator is capable of communicating with a computer or a computer network.
37. The system of claim 32 wherein the hermetically sealed housing for the RFID chip is disposed within a non-hermetically sealed portion of the medical device.
38. The system of claim 32 wherein the hermetically sealed housing for the RFID chip is disposed within a header block of the medical device.
39. The system of claim 32 wherein the antenna wire and the RFID chip are disposed within the medical device parallel to a length and height plane of the medical device, and midway through the width thereof.
40. The system old aim 32 wherein the RFID chip includes information pertaining to the medical device.
41. The system of claim 32 wherein the implantable medical device is selected from the group consisting of a cardiac pacemaker, an implantable defibrillator, a congestive heart failure device, a hearing implant, a cochlear implant, a neurostimulator, a drug pump, a ventricular assist device, an insulin pump, a spinal cord stimulator, an implantable sensing system, a deep brain stimulator, an artificial heart, an incontinence device, a vagus nerve stimulator, a bone growth stimulator, a gastric pacemaker, a Bion or a prosthetic device, and component parts thereof, including lead wires and abandoned lead wire.
4376441 | March 15, 1983 | Duncan |
4424551 | January 3, 1984 | Stevenson et al. |
4846158 | July 11, 1989 | Teranishi |
5333095 | July 26, 1994 | Stevenson et al. |
5336158 | August 9, 1994 | Huggins et al. |
5342408 | August 30, 1994 | deCoriolis et al. |
5855609 | January 5, 1999 | Knapp |
5905627 | May 18, 1999 | Brendel et al. |
5963132 | October 5, 1999 | Yoakum |
6216038 | April 10, 2001 | Hartlaub et al. |
6259937 | July 10, 2001 | Schulman et al. |
6275369 | August 14, 2001 | Stevenson et al. |
6342839 | January 29, 2002 | Curkendall et al. |
6375780 | April 23, 2002 | Tuttle et al. |
6566978 | May 20, 2003 | Stevenson et al. |
6735479 | May 11, 2004 | Fabian et al. |
6765779 | July 20, 2004 | Stevenson et al. |
6957107 | October 18, 2005 | Rogers et al. |
7017822 | March 28, 2006 | Aisenbrey |
7103413 | September 5, 2006 | Swanson et al. |
7174201 | February 6, 2007 | Govari et al. |
7240833 | July 10, 2007 | Zarembo |
7256695 | August 14, 2007 | Hamel et al. |
7333013 | February 19, 2008 | Berger |
7479108 | January 20, 2009 | Rini et al. |
7916013 | March 29, 2011 | Stevenson |
8253555 | August 28, 2012 | Stevenson et al. |
20020049482 | April 25, 2002 | Fabian et al. |
20020151770 | October 17, 2002 | Noll et al. |
20030181794 | September 25, 2003 | Rini et al. |
20050247319 | November 10, 2005 | Berger |
20050258242 | November 24, 2005 | Zarembo |
20060183979 | August 17, 2006 | Rini et al. |
20080048855 | February 28, 2008 | Berger |
20080065181 | March 13, 2008 | Stevenson |
0534782 | March 1983 | EP |
0619101 | October 1994 | EP |
96/11722 | April 1996 | WO |
WO 96/11722 | April 1996 | WO |
- U.S. Appl. No. 60/478,717, filed Jun. 16, 2003, Off.
- Wesley J. Clement and Bob Stevenson, Determination of Effective Lead Loop Area for Implantable Pulse Generators and Cardioverter/Defibrillators for Determination of Susceptibility to Radiated Electromagnetic Interference, Heart Rhythm 2005, May 5, 2005, Abstract 05-AB-2928-HRS, New Orleans, LA.
- Wesley J. Clement and Bob Stevenson; Lead Loop Area Measurement of Implantable Pulse Generations and Cardioverter/Defibrillators for Determination of Susceptibility to Radiated Electromagnetic Interference; Heart Rhythm 2005; May 5, 2005; Abstract: 05-AB-2928-HRS, New Orleans, LA.
Type: Grant
Filed: Nov 22, 2013
Date of Patent: Jul 22, 2014
Assignee: Greatbatch Ltd. (Clarence, NY)
Inventors: Robert A. Stevenson (Canyon Country, CA), Christine A. Frysz (Orchard Park, NY)
Primary Examiner: Anh V La
Application Number: 14/087,734
International Classification: G08B 1/08 (20060101); A61B 5/00 (20060101); A61B 19/00 (20060101); G06K 19/077 (20060101); A61N 1/37 (20060101); A61N 1/372 (20060101); A61N 1/375 (20060101);